Klaria Pharma Holding AB (publ.) (OM: KLAR)
Health Care · Pharmaceuticals · SE
Skr0.53
-2.58% today · +10.6% 1Y
Klaria Pharma Holding AB (publ.) (OM: KLAR) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $13.36M and employs 4 people.
Over the last twelve months the share price has gained 10.6%, trading between 0.45 and 1.33.
Tweenvest scores Klaria Pharma Holding AB (publ.) across four factors: quality 24/100, value 46/100. Its strongest factor is value.
KLAR price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $13.36M
- Revenue (TTM)
- $10.32K
- P/E
- —
- EPS
- -0.20
- Dividend yield
- —
- Beta (5Y)
- 1.29
- 52-week high
- Skr1.33
- 52-week low
- Skr0.45
- Avg volume (3M)
- —
- Shares outstanding
- 245.98M
- Employees
- 4
- Next earnings
- —
About Klaria Pharma Holding AB (publ.)
Klaria Pharma Holding AB (publ.) functions as a pharmaceutical enterprise, active both in Sweden and across global territories. Its current portfolio features Sumatriptan for migraine management and Midazolam for combating acute epileptic seizures. Within its pipeline, Klaria is developing Epinephrine/Adrenaline to address severe allergic responses, Naloxone for reversing opioid overdoses, and Ketamine for applications in acute pain and mood disorders. Moreover, the company is actively involved in bringing cannabis/cannabinoid products, including THC and CBD, to market for medical and recreational purposes. Established in 2014, Klaria is headquartered in Uppsala, Sweden.
- ISIN
- SE0007280326
- Founded
- 2014
- Listed since
- Oct 21, 2015
- Exchange
- OMX Nordic Exchange Stockholm
- Currency
- SEK
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| WooGene B&G Co., LtdKOSDAQ: A018620 | $13.72M | ₩2,660.00 | -0.19% |
| Citius Pharmaceuticals, Inc.NasdaqCM: CTXR | $13.71M | $0.48 | -3.62% |
| Lactose (India) LimitedBSE: 524202 | $13.52M | Rs103.95 | -1.38% |
| PT Phapros TbkIDX: PEHA | $13.52M | Rp288.00 | +2.86% |
| Ayr Wellness Inc.CNSX: AYR.A | $13.21M | CA$— | — |
| Indo-Bangla Pharmaceuticals LimitedDSE: IBP | $13.02M | Tk13.80 | -5.48% |
| Silco Pharmaceuticals LimitedDSE: SILCOPHL | $12.90M | Tk15.30 | -8.38% |
| Anebulo Pharmaceuticals, Inc.OTCPK: ANEB | $12.85M | $0.32 | -1.56% |
Figures last refreshed Oct 11, 2026.